000130180 001__ 130180
000130180 005__ 20240228143414.0
000130180 0247_ $$2doi$$a10.1186/s12967-016-0983-9
000130180 0247_ $$2pmid$$apmid:27473163
000130180 0247_ $$2pmc$$apmc:PMC4966793
000130180 0247_ $$2altmetric$$aaltmetric:10133816
000130180 037__ $$aDKFZ-2017-05260
000130180 041__ $$aeng
000130180 082__ $$a610
000130180 1001_ $$aMiyan, M.$$b0
000130180 245__ $$aDifferential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.
000130180 260__ $$aLondon$$bBioMed Central$$c2016
000130180 3367_ $$2DRIVER$$aarticle
000130180 3367_ $$2DataCite$$aOutput Types/Journal article
000130180 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1524833338_15114
000130180 3367_ $$2BibTeX$$aARTICLE
000130180 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000130180 3367_ $$00$$2EndNote$$aJournal Article
000130180 520__ $$aMolecular subtypes of breast cancer and presence of tumor-infiltrating immune cells have both been implicated as important predictive and prognostic factors for improved risk stratification and treatment individualization of breast cancer patients. Their association, however, has not been studied in detail. The aim of this study was to evaluate the expression of the T cell markers CD8, FoxP3, CD3 and ζ-chain in molecular subtypes of the invasive margin and tumor center of breast cancer and corresponding sentinel nodes and to deduct prognostic information from these findings.Tumor and sentinel node sections from 177 patients with primary, invasive, unilateral early-stage breast cancer were stained by immunohistochemistry and T-cell phenotypes quantified manually. Clinical data were collected from medical records.The degree of T-cell infiltration and expression of all markers differed significantly among the molecular subtypes, being highest in non-luminal, more aggressive tumors: more T-cell infiltration and higher expression of all markers were associated with hormone receptor negativity, higher proliferation and higher histological grades, but also with larger tumor size. Basal-like tumors, and most remarkably their tumor centers, hosted the highest number of FoxP3+ T-cells with an unfavorable ratio to cytotoxic CD8+ T-cells. T-cell infiltration was generally higher in the invasive margin than the tumor center. A scoring system based on densities of CD3 and CD8 could significantly separate molecular subtypes (p < 0.001).Thus, immunological patterns with functional implications within each subtype are associated with prognostic factors. These findings should be further validated in studies using larger patient populations and longer follow-up.
000130180 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000130180 588__ $$aDataset connected to CrossRef, PubMed,
000130180 650_7 $$2NLM Chemicals$$aAntigens, CD
000130180 650_7 $$2NLM Chemicals$$aBiomarkers
000130180 7001_ $$aSchmidt-Mende, J.$$b1
000130180 7001_ $$aKiessling, R.$$b2
000130180 7001_ $$0P:(DE-He78)e9c55f46b4b06cf835834ee7e3e00db8$$aPoschke, I.$$b3$$udkfz
000130180 7001_ $$00000-0001-9518-0902$$ade Boniface, J.$$b4
000130180 773__ $$0PERI:(DE-600)2118570-0$$a10.1186/s12967-016-0983-9$$gVol. 14, no. 1, p. 227$$n1$$p227$$tJournal of translational medicine$$v14$$x1479-5876$$y2016
000130180 909CO $$ooai:inrepo02.dkfz.de:130180$$pVDB
000130180 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e9c55f46b4b06cf835834ee7e3e00db8$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000130180 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000130180 9141_ $$y2016
000130180 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ TRANSL MED : 2015
000130180 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000130180 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000130180 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000130180 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000130180 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000130180 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000130180 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000130180 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000130180 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000130180 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000130180 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000130180 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000130180 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000130180 9201_ $$0I:(DE-He78)G180-20160331$$kG180$$lMolekulare Grundlagen Gastrointestinaler Tumoren$$x0
000130180 980__ $$ajournal
000130180 980__ $$aVDB
000130180 980__ $$aI:(DE-He78)G180-20160331
000130180 980__ $$aUNRESTRICTED